Bayer Group Key Data

 

 

 

 

 

 

 

 

 

 

 

 

 

3rd Quarter 2014

3rd Quarter 2015

Change

 

First Nine Months 2014

First Nine Months 2015

Change

 

Full Year 2014

 

 

€ million

€ million

%

 

€ million

€ million

%

 

€ million

2014 figures restated

In some cases, the sum of the figures given in this report may not precisely equal the stated totals and percentages may not be exact due to rounding.

1

EBIT = earnings before financial result and taxes

2

EBIT before special items and EBITDA before special items are not defined in the International Financial Reporting Standards and should therefore be regarded only as supplementary information. EBITDA before special items is a meaningful indicator of operating performance since it is not affected by depreciation, amortization, impairments or special items. By reporting this indicator, the company aims to give readers a clear picture of the results of operations and ensure comparability of data over time. See also “Calculation of EBIT(DA) Before Special Items.”

3

The EBIT(DA) margin before special items is calculated by dividing EBIT(DA) before special items by sales.

4

EBITDA = EBIT plus amortization and impairment losses on intangible assets and depreciation and impairment losses on property, plant and equipment, minus impairment loss reversals

5

Earnings per share as defined in IAS 33 = net income divided by the average number of shares

6

Core earnings per share are not defined in the International Financial Reporting Standards. By reporting this indicator, the company aims to give readers a clear picture of the results of operations and ensure comparability of data over time. The calculation of core earnings per share is explained in ”Core Earnings Per Share.”

7

Gross cash flow = income after income taxes, plus income taxes, plus financial result, minus income taxes paid or accrued, plus depreciation, amortization and impairment losses, minus impairment loss reversals, plus / minus changes in pension provisions, minus gains / plus losses on retirements of noncurrent assets, minus gains from the remeasurement of already held assets in step acquisitions. The change in pension provisions includes the elimination of non-cash components of EBIT. It also contains benefit payments during the year. For details see ”Financial Position of the Bayer Group.”

8

Net cash flow = cash flow from operating activities according to IAS 7

9

Full-time equivalents

Sales

 

9,967

11,036

+10.7

 

30,547

35,005

+14.6

 

41,339

Change (adjusted for currency and portfolio effects)

 

 

 

+1.9

 

 

 

+2.8

 

+7.7%

 

 

 

 

 

 

 

 

 

 

 

Change in sales

 

 

 

 

 

 

 

 

 

 

Volume

 

+6.8%

+4.3%

 

 

+7.0%

+4.0%

 

 

+7.1%

Price

 

+0.6%

−2.4%

 

 

+0.3%

−1.2%

 

 

+0.6%

Currency

 

−1.7%

+4.9%

 

 

−4.3%

+7.1%

 

 

−2.8%

Portfolio

 

−0.1%

+3.9%

 

 

+0.1%

+4.7%

 

 

+0.7%

 

 

 

 

 

 

 

 

 

 

 

EBIT1

 

1,346

1,565

+16.3

 

4,846

5,342

+10.2

 

5,395

Special items

 

45

(204)

 

 

4

(703)

 

 

(438)

EBIT before special items2

 

1,301

1,769

+36.0

 

4,842

6,045

+24.8

 

5,833

 

 

 

 

 

 

 

 

 

 

 

EBIT margin before special items3

 

13.1%

16.0%

 

 

15.9%

17.3%

 

 

14.1%

 

 

 

 

 

 

 

 

 

 

 

EBITDA4

 

2,023

2,325

+14.9

 

6,868

7,718

+12.4

 

8,315

Special items

 

46

(198)

 

 

12

(645)

 

 

(370)

EBITDA before special items2

 

1,977

2,523

+27.6

 

6,856

8,363

+22.0

 

8,685

 

 

 

 

 

 

 

 

 

 

 

EBITDA margin before special items3

 

19.8%

22.9%

 

 

22.4%

23.9%

 

 

21.0%

 

 

 

 

 

 

 

 

 

 

 

Financial result

 

(302)

(280)

+7.3

 

(634)

(841)

−32.6

 

(981)

 

 

 

 

 

 

 

 

 

 

 

Net income (from continuing and discontinued operations)

 

826

999

+20.9

 

3,202

3,497

+9.2

 

3,426

Earnings per share (from continuing and discontinued operations) (€)5

 

1.00

1.21

+21.0

 

3.87

4.23

+9.3

 

4.14

 

 

 

 

 

 

 

 

 

 

 

Core earnings per share (from continuing operations) (€)6

 

1.32

1.69

+28.0

 

4.72

5.76

+22.0

 

5.89

 

 

 

 

 

 

 

 

 

 

 

Gross cash flow7

 

1,466

1,427

−2.7

 

5,149

5,611

+9.0

 

6,707

 

 

 

 

 

 

 

 

 

 

 

Net cash flow8

 

1,816

2,330

+28.3

 

3,580

5,013

+40.0

 

5,810

 

 

 

 

 

 

 

 

 

 

 

Cash outflows for capital expenditures

 

546

655

+20.0

 

1,432

1,601

+11.8

 

2,371

 

 

 

 

 

 

 

 

 

 

 

Research and development expenses

 

867

1,041

+20.1

 

2,520

3,023

+20.0

 

3,537

 

 

 

 

 

 

 

 

 

 

 

Depreciation, amortization and impairments

 

677

760

+12.3

 

2,022

2,376

+17.5

 

2,920

 

 

 

 

 

 

 

 

 

 

 

Number of employees at end of period9

 

112,831

117,866

+4.5

 

112,831

117,866

+4.5

 

117,371

Personnel expenses (including pension expenses)

 

2,331

2,739

+17.5

 

7,080

8,369

+18.2

 

9,693